Science & Technology

New antibiotic delivery system could improve cancer treatment

The strategy, according to researchers, may specifically be useful in treating infected cancer cells where conventional antibacterial agents cannot reach

 
By Swati Subodh
Last Updated: Friday 28 July 2017 | 07:21:12 AM
Researchers have used nanoparticles bound with molecules in the new delivery system (Credit Thinkstock)
Researchers have used nanoparticles bound with molecules in the new delivery system (Credit Thinkstock) Researchers have used nanoparticles bound with molecules in the new delivery system (Credit Thinkstock)

An all-woman team of Indian scientists has developed a novel antibiotic delivery system that enhances action of drugs at cellular level and overall efficiency of conventional antibiotics. The system could help improve cancer treatment in future.

Development of antibiotic resistance due to inefficient and indiscriminate use of antibiotics poses a treatment challenge. The severity of the problem increases in patients with weak immune system like in cancers. In the absence of new and more potent antibiotics or other viable alternatives, scientists are focusing on improving efficacy of existing options.

Researchers at the Indian Institute of Technology Delhi (IIT-D) have used nanoconjugates—nanoparticles bound with molecules to render them with added biological features—in this context. The new study demonstrates that the nanoparticle-bound antibacterial agent, a short molecule called sushi-peptide, was more efficient than anti-bacterial agent alone.

“We used nanoparticles as efficient delivery vehicles for the antibiotic and cancer cell-specific biomarkers for specific targeting,” explained Shalini Gupta, one of the lead researchers of the study published in journal Scientific Reports.

The strategy, according to researchers, may specifically be useful in treating infected cancer cells where conventional antibacterial agents cannot reach. Gupta elaborates, “our strategy is to reach and kill these bacteria that lie hidden inside the cancer cells”.  The study demonstrates this by effectively eliminating E.Coli and S.typhi bacteria in cells under laboratory conditions.

The gold nanoparticle-based conjugate was efficiently taken up by the cell and demonstrated no toxicity. Adding to this, Neetu Singh, another member of the research team, said, “the nanoparticle system offers a platform for new generation of antibiotics, which are active at much lower dosages thus addressing a very common problem of bacteria developing resistance to most of the known antibiotics due to overdosing."

The study team included Rohini Singh, Smita Patil, Neetu Singh and Shalini Gupta. (India Science Wire)

Subscribe to Weekly Newsletter :

Related Story:

New vaccine protects against Ebola when administered seven days before infection: Study

Third gene imparting resistance to last resort antibiotic discovered

One test to detect different types of cancers

Liver fibrosis can be detected through blood test: new study

IEP Resources:

Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity

SC83288 is a clinical development candidate for the treatment of severe malaria

Dissemination of antibiotic resistance genes from antibiotic producers to pathogens

Chalcone-based aryloxypropanolamine as a potential antidiabetic and antidyslipidaemic agent

We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.

Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.